New research shows that a key regulatory enzyme inhibitor discovered in the laboratory of Bruce Hammock, Ph.D. can alleviate inflammation linked to health issues that are caused by a high-sugar diet. The study, conducted in a mouse model, show promise as a basis for developing treatments of gut barrier dysfunction caused by high sugar consumption in humans.